title: Clinical applications of proteomics.
abstract: Proteomics, the systematic evaluation of changes in the protein constituency of a cell, is more than just the generation of lists of proteins that increase or decrease in expression as a cause or consequence of disease. The ultimate goal is to characterize the information flow through protein pathways that interconnect the extracellular microenvironment with the control of gene transcription. The nature of this information can be a cause or a consequence of disease processes. Clinical applications of proteomics involve the use of proteomic technologies at the bedside. The analysis of human cancer as a model for how proteomics can have an impact at the bedside is now employing several new proteomic technologies that are being developed for early detection, therapeutic targeting and finally, patient-tailored therapy.
authors.affiliation: U. S. Food and Drug Administration-National Cancer Institute Clinical Proteomics Program, Center for Biologic Evaluation and Research, U. S. Food and Drug Administration, Rockville, MD 20852, USA. petricoin@cber.fda.gov
authors.forename: Emanuel F
authors.initials: EF
authors.lastname: Petricoin
authors.forename: Lance A
authors.initials: LA
authors.lastname: Liotta
mesh_terms: D020869:Gene Expression Profiling; D006801:Humans; D008967:Molecular Biology; D025202:Molecular Diagnostic Techniques; D009369:Neoplasms / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology; D040081:Protein Array Analysis / Q000379:methods* / Q000706:statistics & numerical data; D040901:Proteomics / Q000145:classification / Q000379:methods / Q000639:trends; D013678:Technology, Pharmaceutical / Q000295:instrumentation / Q000639:trends*